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Abstract
Purpose/background The purpose of this study is to explore
the effect of a moderate dose of alcohol on sleep architecture
and respiration in chronic obstructive pulmonary disease
(COPD). Alcohol depresses both hypercapnic and hypoxic
ventilatory drives in awake, normal individuals and reduces
the amount of rapid eye movement (REM) sleep and oxygen
saturation (SpO2) in sleeping COPD subjects.
Methods Prospectively designed, open-label interventional
study in a pulmonary rehabilitation hospital. Twenty-six (nine
males) stable inpatients, median forced expiratory volume first
second (FEV1) 40.5 % of predicted, median age 65 years,
investigated by polysomnography including transcutaneous
measurement of carbon dioxide pressure increase (ΔPtcCO2)
in randomized order of either control sleep or intervention
with 0.5 g of ethanol/kilogram bodyweight, taken orally im-
mediately before lights off.
Results Alcohol induced a mean increase (95 % confidence
interval, [CI]) in themeanΔPtcCO2 of 0.10 kPa (0.002–0.206,
P=0.047) and a mean decrease (CI) in the REM-sleep
percentage of total sleep time (REM % of TST) of
3.1 % (0.2–6.0), (P=0.020). Six subjects with apnea/
hypopnea index (AHI) ≥15 had fewer apneas/hypopneas dur-
ing alcohol versus control sleep (mean reduction of AHI 11
(1–20), P=0.046). Alcohol-sleep changes in SpO2, but not in
ΔPtcCO2, correlated with daytime arterial pressures of carbon
dioxide (PaCO2) and oxygen (PaO2).
Conclusion Occasional use of a moderate, bedtime dose of
alcohol has only minor respiratory depressant effects on the
majority of COPD subjects, and in a minority even slightly
improves respiration during sleep. However, caution is appro-
priate as this study is small and higher doses of alcohol may
result in major respiratory depressive and additional negative
health effects.
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Introduction
Chronic obstructive pulmonary disease (COPD) has a signif-
icant morbidity and mortality [1], and chronic hypercapnic
respiratory failure (CHRF) in COPD is associated with poor
prognosis [2, 3]. Heavy alcohol consumption has been shown
to increase the risk of developing COPD [4–6]; on the other
hand, mild alcohol intake may reduce the risk both of devel-
oping severe pulmonary function abnormalities and of dying
from COPD [7, 8]. Sleep is characterized by periods of unsta-
ble respiration, and in normal, awake individuals, hypoxic and
hypercapnic ventilatory drives are depressed by alcohol [9].
Sleep hypoventilation (SH) has previously been shown to be
frequent in severe COPD with CHRF and long-term oxygen
therapy (LTOT) [10–12], and recently, we also found SH in
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some normocapnic, non-LTOT individuals with stable COPD
[12]. Both in a study of 20 asymptomatic men aged 20 to
65 years [13] and in a study of 20 COPD subjects (19 men)
[14], alcohol increased the number of sleep apneas. However,
a study of 18 asymptomatic, postmenopausal women found
no difference between placebo- and alcohol-influenced sleep
in the number of episodes of apnea or hypopnea or in the
frequency, length, or severity of oxygen desaturation [15]. In
two small studies of four normal individuals and five subjects
with stable COPD, alcohol taken immediately before sleep
resulted in a moderately reduced mean SpO2 and a reduced
amount of rapid eye movement (REM) sleep [16, 17]. To our
knowledge, no studies have explored alcohol-induced chang-
es in carbon dioxide pressure (PCO2) with polysomnography
(PSG) in sleeping COPD patients. Concern is thus raised
whether it is safe for individuals with COPD, especially those
with CHRF or frequent apneas/hypopneas, to occasionally
consume alcohol before sleep.
Hypothesizing an increase in the PCO2 during sleep,
the primary aim of this study was to explore to what
extent a moderate dose of alcohol prior to sleep induces
hypoventilation in stable COPD patients, secondary
whether apneas/hypopneas and sleep architecture is al-
tered, and finally whether the alcohol-induced changes
in blood gases during sleep is correlated to daytime
COPD characteristics.
Material and methods
Subjects
Study participants were a randomized selection from the 166
subjects described in a previous article [12], all Caucasians
with GOLD [18] defined COPD and inpatients at the
Glittreklinikken Pulmonary Rehabilitation Hospital included
from January 2010 through June 2011. The following exclu-
sion criteria were used: diagnosed obstructive sleep apnea
(OSA); COPD exacerbation within 3 weeks prior; other seri-
ous lung comorbidity (i.e., cancer, sarcoidosis, restrictive lung
disease) or diseases affecting thoracic or abdominal move-
ment, unstable angina pectoris, hypertension, diabetes
mellitus, myocardial infarction within last 3 months, cerebral
infarction, and addiction to drugs, alcohol, or narcotics. At
inclusion, study subjects were randomized to receive alcohol,
5 mg of Zopiclone (a sleep drug), or supplementary oxygen
(data from the latter two interventions not yet published). All
subjects used prescribed medication, but no drugs known to
be respiratory depressants were taken from 48 h prior to first
PSG recording until end of study. The protocol was approved
by the Regional Ethics Committee in south-eastern Norway.
As shown in Fig. 1, 26 pairs of PSG from control and alcohol-
influenced sleep were analyzed.
Measurements
All subjects slept in their own bed at the hospital with full PSG
for three nights; first night for acquaintance with the equip-
ment, second and third nights randomized to either control or
alcohol-influenced sleep. PSG was recorded online from
Embla A101 with transcutaneously measured carbon dioxide
pressure (PtcCO2) from Tosca 500
2 to a bedside computer
using Somnologica Studio Version 3.3 software. Channel
setup was according to the 2007 recommendations from the
American Academy of Sleep Medicine (AASM) [19]. PSGs
were recorded only during weekdays. Alcohol 0.5 mg per kg
bodyweight (corresponding to about three glasses of wine in a
70-kg person) was given as 96 vol% ethanol diluted in 200 ml
of orange juice and ingested the last 30 min prior to sleep [20].
Immediately before lights off, breath analysis by Lion
alcometer 5003 was used to check that study-alcohol was taken.
Unpublished data collected at Glittreklinikken prior to
the study showed equivalence between changes in PtcCO2
and PaCO2, but a delay time of 54–57 s. Details regarding
delay time, PtcCO2 signal stabilization, sampling frequency,
and calculations according to sleep stages are given in our
previous article [12].
Fig. 1 Inclusion
1 Medcare Flaga, Reykjavik, Iceland.
2 Radiometer, Basel, Switzerland.
3 Lion Laboratories Ltd., Vale of Glamorgan, UK.
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Arterial blood gas samples4 were collected after a 10-min
seated rest at approximately 2 p.m. prior to each PSG record-
ing and analyzed within 10 min on the Radiometer
ABL720Flex.5 At sampling, all subjects were breathing room
air, with an exception for those on LTOT who used their
prescribed dose of supplementary oxygen. Height, weight,
and lung function tests including postbronchodilator spirom-
etry, diffusing capacity (DLCO), and body plesmography of
total lung volumes were recorded on MasterScreen Pneumo6
as previously described [12], reference values are based on
equations from the European Community for Coal and Steel
[21].
S leep scor ing was done by two exper ienced
polysomnographists according to recommendations from the
AASM [12, 19]; a hypopnea was scored when nasal pressure
dropped ≥30 % for ≥10 s with ≥4 % desaturation drop from
baseline, with ≥90 % of the event’s duration meeting the
amplitude reduction criteria for hypopnea (criterion A).
Sleep hypoventilation is defined by the AASM as an increase
of 1.3 kPa or more in PaCO2 during sleep, to a value exceed-
ing 6.7 kPa for at least 10 min [22].
Statistical analysis
Sample size calculations up front showed that for N=28, a
PtcCO2 difference between alcohol and control sleep would be
detected with 80 % probability at a two-sided 0.05 signifi-
cance level if the true difference was 0.25 kPa, assuming a
within-patient standard deviation of 0.32 kPa7
Data were assessed for normality of distribution and ho-
mogeneity of variance. No violation of the assumptions of
normality, linearity, multicolinearity, and homoscedasticity
was found preliminary to regression analysis.
Differences between groups with continuous, paired para-
metric data were analyzed with Student T, paired non-
parametric data with Wilcoxon signed rank, independent
non-parametric data with Mann-Whitney U, and non-
parametric data in more than two groups by Kruskal-Wallis
tests. Paired proportions were analyzed with McNemar chi-
square test (P value uncorrected) and correlations with
Pearson’s r.
Two-sided P values of ≤0.05 were considered significant in
testing the main hypothesis, whereas a significance level of
P≤0.025 was applied in the remaining analyses. All analyses
were performed using IBM SPSS Statistics version 19.
Results
The 9 men and 17 female (Table 1) were on average hyper-
inflated with impaired gas exchange and severe airway ob-
struction, 14 (54 %) of the 26 subjects at GOLD stages III and
IV. Four subjects (16 %) had daytime hypoxemia (arterial
pressures of oxygen (PaO2)<8.0 kPa), whereas only one had
PaO2>12.0 kPa. CHRF (PaCO2≥6.3 kPa) was found in four
subjects, of which three used LTOT. The study group had a
normal median BMI, five subjects (19 %) being underweight
(BMI<21), whereas five were obese (BMI≥30).
As indicated in Table 2, alcohol at bedtime reduced the
REM-sleep percentage of total sleep time (REM % of TST)
with a mean (SD) of 3 (7) %, and the number of awakenings
with 8 (13). However, eight subjects had an increased amount of
REM sleep when influenced by alcohol (Fig. 2, groups 2 and 4).
The mean PtcCO2 increase from supine, resting value prior
to sleep (ΔPtcCO2) was higher during alcohol versus control
sleep (a mean (SD) increase of 0.10 (0.25) kPa), despite nine
subjects having a decrease in the mean ΔPtcCO2 (Fig. 2,
groups 3 and 4). As shown in Table 4, alcohol-sleep changes
in mean ΔPtcCO2 and mean SpO2 did not correlate.
Sleep hypoventilation (SH) as defined by the AASM was
found in two subjects (8 %) during control sleep and in five
subjects (19 %) in alcohol sleep [22]; however, the difference
was not statistically significant as one subject with SH in
control sleep had no SH during alcohol sleep.
Ten subjects had a drop in alcohol-sleep mean SpO2 of
>1 %, whereas the NREM sleep mean SpO2 for the whole
study group decreased with a mean (SD) of 0.9 (2.1) %
(P=.019). No significant change was found in REM sleep
(Table 2). Interestingly, Table 2 also shows no respiratory
depressant effect of alcohol during the awake periods after
the initial sleep onset (N0) nor was there significant N0
changes in mean ΔPtcCO2 and mean SpO2 when analyzing
only subjects with alcohol increased sleep mean ΔPtcCO2
(groups 1 and 2, Fig. 2).
The median values of apneas/hypopneas and desaturations
per hour of sleep (AHI and ODI, respectively) were not
changed by alcohol. Despite the exclusion of diagnosed
OSA prior to the study, six subjects (four males) had an AHI
of ≥15 per hour in control sleep. Intriguingly, Table 3 indicates
that this subgroup had alcohol sleep decreases in median AHI
and ODI, all with increased mean ΔPtcCO2 and decreased
REM % of TST.
As the three LTOT users were outliers in the data distribu-
tion of the mean SpO2 change, partial correlation was applied,
controlling for LTOT use (yes/no). Alcohol-sleep changes in
the mean SpO2 (ΔASSpO2) were highly correlated to daytime
PaO2 and inversely to PaCO2 (Table 4). However, this was not
the case regarding the alcohol-sleep changes in the mean
ΔPtcCO2 nor did hypoventilation during alcohol sleep corre-
late to spirometry or demographic data.
4 PICO50, Radiometer, Copenhagen, Denmark.
5 Radiometer, Copenhagen, Denmark.
6 Jaeger-Toennies, Hoechberg, Germany.
7 In our previous study of 100 COPD subjects [12], the mean
increase (standard deviation) in PtcCO2 during spontaneous sleep was
0.49 (0.32) kPa.
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Finally, hierarchical multiple regressions were performed to
determine whether the ΔASSpO2 could be explained by day-
time COPD characteristics. PaO2 and PaCO2 were entered at
step 1, explaining 34 % of the variance in ΔASSpO2. After the
entry of LTOT (yes/no) at step 2, the total variance explained
by the model was 49 %, (F(3, 22)=7.09, P=0.002). Thus,
LTOT (yes/no) explained an additional 15 % of the variance in
the ΔASSpO2 after controlling for PaO2 and PaCO2 (R2
change=0.015, F change (1, 22)=6.48, P=0.018). In the full
model, using LTOT recorded the highest beta value (0.70,
P<.018), over PaCO2 (−0.59, P<0.031), whereas PaO2 did
not make a unique contribution (0.31, P=0.116).
Table 2 Control versus alcohol-influenced sleep
N=26 Control sleep
Median (IQR)
Alcohol sleep
Median (IQR)
P value
Sleep architecture
TST, min 354.0 (65.3) 354.0 (62.5) 0.501
REM % of TST 25 (8) 20 (9) 0.020
NREM % of TST 75 (8) 80 (9) 0.020
WASO, min 45.7 (74.7) 40.9 (48.5) 0.361
Awakenings 28 (18) 19 (17) 0.012
AI 15.5 (10.0) 18.6 (10.0) 0.920
Ventilation
AHI 9.7 (10.2) 10.4 (16.4) 0.517
HI 4.8 (6.2) 6.3 (8.6) 0.309
ODIa 5.5 (11.6) 8.3 (12.8) 0.548
Mean SpO2 %
N0 94.0 (5.1) 93.9 (5.6) 0.551
NREM 93.7 (4.6) 93.2 (5.4) 0.019
REM 92.5 (5.4) 92.8 (6.4) 0.258
Sleep 93.4 (4.7) 93.2 (5.7) 0.058
Mean ΔPtcCO2 kPa
N0 0.19 (0.23) 0.15 (0.22) 0.638
NREM 0.39 (0.34) 0.55 (0.36) 0.035
REM 0.67 (0.46) 0.67 (0.42) 0.082
Sleep 0.49 (0.35) 0.58 (0.36) 0.047
Sleep hypoventilation
SHb 8 (27) 19 (40) 0.179
TST total sleep time, REM rapid eye movement sleep, NREM non-REM
sleep, WASO wake after sleep onset, Awakenings number of awakenings
after sleep onset, AI number of arousals per hour (arousal index), AHI
number of apneas/hypopneas per hour (apnea/hypopnea index), HI num-
ber of hypopneas per hour (hypopnea index), ODI number of oxygen
desaturations per hour (oxygen desaturation index), SpO2 oxyhemoglobin
saturation by pulse oximetry, N0 awake after initial sleep onset, Sleep=
NREM + REM,ΔPtcCO2 carbon dioxide pressure increase from supine,
resting value prior to sleep, SH sleep hypoventilation defined by the
American Academy of Sleep Medicine as an increase of 1.3 kPa or more
in PaCO2 during sleep, to a value exceeding 6.7 kPa for at least 10 min
aN=25, one missing because of defect finger probe
b Percent of “Yes” within group (SD), instead of median (IQR)s
Table 1 Study population
N=26
Median (IQR)
Demographic data
Gender female 17 (65)a
Age, years 65.5 (14.0)
BMI, kg/m2 25.0 (6.5)
Smoking habit
Pack years 30.4 (22.4)
Current smoker 4 (15)a
Medication
LTOT 3 (12)a
SABA/LABA 24 (92)a
Statin 4 (15)a
ACE/AII 3 (12)a
Thiazide 3 (12)a
ASA 3 (12)a
Spirometry
FVC, % of pred 81.0 (35.3)
FEV1, % pred 40.5 (30.3)
FEV1/FVC, ratio 0.46 (0.21)
DLCO1, mmol/min/kPa 3.92 (2.49)
RV/TLC2, ratio 0.56 (0.20)
Clinical data
CAT, score 18 (7)
MMRC, score 2.0 (1.0)
6-MWD3, meter 420 (205)
BODE index 2.0 (4.0)
Laboratory data
PaO2, kPa 9.66 (1.98)
PaCO2, kPa 5.07 (.96)
SaO2, % 96.2 (3.3)
Alcohol, ppt 0.81 (0.64)
IQR inter quartile range, BMI body mass index, LTOT long-term oxygen
therapy, SABA/LABA short- and/or long-acting beta-2 receptor agonist,
ACE/AII angiotensin converting enzyme and/or angiotensin II antagonist,
Thiazide hydrochlorothiazide, ASA acetylic salicylic acid, FVC% of pred
forced vital capacity as percent of predicted value, FEV1% of pred forced
expiratory volume first second as percent of predicted value, DLCO
diffusing capacity of the lung for carbon monoxide, RV residual volume,
TLC total lung capacity, CAT COPD assessment test, MMRC modified
medical research council questionnaire, 6-MWD 6 min walking distance,
BODEBMI/obstruction/dyspnea/exercise capacity, PaO2 arterial pressure
of oxygen, PaCO2 arterial pressure of carbon dioxide, SaO2 arterial
oxygen saturation,. Alcohol parts per thousand measured by breath anal-
ysis immediately prior to sleep
aN (% of study subjects), instead of median (IQR)
1N=22, four missing fromDLCObecause of insufficient vital capacity or
because they could not hold their breath for 10 s
2 N=24, two missing from body plethysmography because of
claustrophobia
3N=25, one missing from 6-MWD, reason unknown
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Discussion
When stable COPD subjects (2/3 female) are given a moderate
dose of alcohol immediately prior to sleep, we find a very
modest sleep hypoventilation as a group mean increase in
PtcCO2 of about 0.1 kPa and a decrease in SpO2 of less than
1 %. This hypoventilation is not detectable when subjects are
awake after the initial sleep onset. The mean REM % of TST
is decreased in alcohol sleep. A novel finding is subgroups
showing opposite characteristics as slight hyperventilation
with decreased amount of REM sleep and hypoventilation
with increased REM percentage of TST. AHI and ODI are
not significantly increased by alcohol; however, in overlap
subjects (AHI ≥15/h), AHI and ODI are lower. Alcohol-sleep
change in SpO2, but not PtcCO2, is associated to daytime blood
gases, and a model with LTOT, PaCO2, and PaO2 can explain
about half of the variation in alcohol sleep change in SpO2.
In a much referred study from 1967, Yules et al. gave 1 g of
ethanol/kg body weight to four male graduate students 4 h
prior to sleep and found that the REM-sleep time reduced as a
mean for the group; however, one subject showed no change
in REM-sleep time [16]. Later, Easton et al. gave five COPD
subjects 0.78 g of alcohol/kg bodyweight immediately prior to
sleep and found a mean TST decrease of 19 %, a REM-sleep
percentage of TST decrease by 12 % and a mean drop in SpO2
of about 3 % [17]. In 2007, Brander et al. studied nine males
with advanced COPD using 0.5 g of alcohol/kg bodyweight
albeit taken earlier in the evening, they did not record PSG but
found only a trivial decrease in SpO2 (<1 %) during the first
2 h of the reported sleep [23].
In the present study, we find REM % of TST decreased as
in the studies referred above, however, only in 18 (69 %) of
the subjects. One possible explanation for the eight subjects
showing increased REM% of TSTcan be alcohol abstinence.
Easton et al. found the REM % of TST gradually increasing
when giving alcohol repeatedly for several nights. Although
none of our study subjects had a drinking problem (otherwise
they would not have been included), some could nevertheless
have used alcohol regularly before admission, and thus the
abstinent state during the first week at the hospital might
explain the increase in REM sleep when given alcohol.
However, we find it unlikely that as many as 31 % of the
study subjects had an undisclosed alcohol problem, and as
Yules et al. also described one subject with no change in
REM-sleep time [16], hitherto unknown effects of alcohol
on sleep can have caused the increased mean REM % of
TST in some of the subjects in the present study (Fig. 2).
In a previous article, we showed that ΔPtcCO2 increases
with depth of NREM sleep in stable COPD and with the
highest values recorded during REM sleep [12]. Thus, finding
the REM percentage of TST being reduced in alcohol sleep,
one would expect to find the meanΔPtcCO2 to be decreased.
Indeed, although not clinically impressive, the seven (27 %)
Fig. 2 Alcohol-induced changes in mean ΔPtcCO2 versus changes in
REM-sleep percentage of TST. Each subject (N=26) is represented by a
colored figure according to group (legend in panel). Mean PtcCO2 in
group 1 (median (IQR) 0.26 (0.28) kPa) differed significantly from group
3 (−0.20 (0.23) kPa, P<0.0005), but not from group 2 (0.11(0.10) kPa,
P=0.027). The change in REM percentage of TST was significantly
different between groups 1 and 2 (median (IQR)=−4.5 (6.9) % versus
3.9 (8.9) %, P=0.001). Change in meanΔPtcCO2 is the difference in the
mean increase in transcutaneous carbon dioxide pressure between alcohol
and control sleep. Change in mean REM% of TST is the difference in the
mean rapid eye movement sleep percent of total sleep time between
alcohol and control sleep
Table 3 Alcohol-induced sleep changes in overlap subjects
N=6 (four male) Control sleep
Median (IQR)
Alcohol sleep
Median (IQR)
P value
REM % of TST 25 (12) 21 (15) 0.028
NREM mean ΔPtcCO2, kPa 0.48 (0.39) 0.68 (0.27) 0.028
REM mean ΔPtcCO2, kPa 0.64 (0.63) 0.91 (0.35) 0.028
Sleep mean ΔPtcCO2, kPa 0.51 (0.46) 0.75 (0.28) 0.028
Sleep mean SpO2, % 93.3 (3.8) 93.2 (6.5) 0.075
ODI 32 (28) 24 (22) 0.028
AHI 39 (40) 26 (22) 0.046
REM AHI 49 (43) 36 (28) 0.075
NREM AHI 31 (46) 30 (23) 0.116
As no record of daytime sleepiness was available, overlap was defined as
having at least 15 apneas/hypopneas per hour of sleep in subjects with
chronic obstructive pulmonary disease
NREM mean ΔPtcCO2 mean pressure of transcutaneous carbon dioxide
in non-rapid eye movement sleep, REMmeanΔPtcCO2mean pressure of
transcutaneous carbon dioxide in rapid eye movement sleep, Sleep mean
ΔPtcCO2 mean pressure of transcutaneous carbon dioxide in REM and
NREM sleep, Sleep mean SpO2 mean oxyhemoglobin saturation during
sleep measured by pulse oximetry, REM% of TSTREM-sleep percentage
of total sleep time, AHI number of apneas/hypopneas per hour of sleep,
REM AHI AHI during REM sleep, NREM AHI AHI during NREM sleep
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subjects in group 3 in Fig. 2 fit in this picture. Brief alcohol
exposure is moderately bronco-dilating and increases the
mucociliary motility in asthmatics [24], and thus can relieve
nocturnal wheezing in reversible COPD subjects, and possibly
improve gas exchange in the lungs. However, the 11 (42 %)
subjects with reduced REM % of TST and increased PtcCO2
(group 1, Fig. 2) are more in accordance with previous find-
ings in COPD [17]. The hypoventilation demonstrated in the
present study with only two subjects (8 %) having a mean
alcohol-sleep increase inΔPtcCO2>0.5 kPa and less than half
having a drop in mean SpO2>1 % was considerably less
impressive than Easton et al.’s findings and more in line with
the results of Brander et al.[17, 23]. One obvious explanation
is the amount of alcohol and the time of ingestion related to
sleep onset, as Brander et al. gave less alcohol earlier in the
evening compared to Easton et al., the present study using
same amount of alcohol as Brander et al., but given immedi-
ately before lights off. Thus, as REM sleep is more frequent
the second half of the night when most of the alcohol is
metabolized, REM-sleep hypoventilation is not significantly
changed. Another explanation can be the number of study
subjects; as previous studies included only up to six subjects,
they could have missed the individuals having decreased
PtcCO2 during alcohol sleep.
Previous studies have shown increased numbers of apneas
in alcohol-sleep in asymptomatic and in snoring males, in
mild to moderate OSA-males and in male, but not in female
COPD subjects [13, 25, 26, 14, 15]. The present study did not
find AHI, HI, and ODI significantly increased by alcohol.
This can partly be explained by the majority of female subjects
in the present study. Also, as apneas/hypopneas are most
frequent in REM sleep, occurring at low alcohol content, the
reduced REM% of TST in alcohol-sleep can result in the total
AHI being unchanged. However, the subgroup of mostly men
with control sleep AHI≥15/h having decreased AHI and ODI
during alcohol sleep seems to contradict previous findings in
males. All these individuals are hypoventilating, yet they have
fewer apneas, and although not statistically significant, the
REM-sleep AHI tends to be lower in alcohol-sleep. A reduced
tidal volume with increased frequency of respiration, shorter
episodes of REM-sleep, less mucus, and reduced bronchial
constriction can be possible explanations.
Interestingly, no changes are found inΔPtcCO2 or SpO2 in
N0 (awake after initial sleep onset), suggesting that
moderate doses of alcohol has a significant effect on the
central respiratory control only during sleep. This is in support
of Sahn et al., who did not find significant alcohol-induced
hypoventilation (neither as decreased PO2 nor increased
PCO2) in six awake subjects with severe COPD after drinking
0.78 g of alcohol/kg bodyweight [27].
Having COPD with daytime respiratory failure correlates
with alcohol-induced sleep hypoventilation, however, only as
daytime blood gases versus ΔASSpO2, and not hypoventilation
as change in mean ΔPtcCO2 (Table 4). As the multiple linear
regressions with the variables LTOT, PaO2, and PaCO2 can
explain only half of the decrease in SpO2 in alcohol sleep,
advice to COPD patients regarding the use of alcohol cannot
be based on whether they have respiratory failure or not. Nor
is the severity of COPD according to FEV1 as percentage of
predicted, the transfer factor for carbon monoxide (DLCO) or
the residual volume as percentage of total lung volume (RV/
TLC) highly associated with the alcohol-induced sleep
hypoventilation.
This study is to our knowledge the first to explore sleep
hypoventilation as both oxygen desaturation and carbon diox-
ide increase in moderately alcohol-intoxicated COPD
Table 4 Correlation between alcohol-induced blood gas changes in sleep
and study population characteristics
N=26 Change in mean
SpO2
a
Change in mean
ΔPtcCO2
Pearson’s r P value Pearson’s r P value
Demographic data
Age, years −0.11 0.616 0.02 0.914
Gender 0.08 0.709 0.06 0.784
BMI kg/m2 −0.13 0.543 0.13 0.516
Laboratory data
PaO2, kPa 0.51 0.009 −0.25 0.227
PaCO2, kPa −0.58 0.002 0.11 0.604
pH 0.37 0.071 0.05 0.816
Spirometry
FVC % of pred 0.28 0.170 −0.04 0.855
FEV1 % of pred 0.32 0.125 −0.03 0.886
DLCO mmol/min/kPab 0.32 0.161 −0.23 0.308
RV/TLC ratioc −0.28 0.202 0.01 0.950
Sleep
Change in REM % of
TST
0.12 0.554 −0.15 0.454
Change in awakenings −0.11 0.602 0.22 0.274
Change in mean SpO2 − − −0.30 0.135
Change in mean SpO2 difference between alcohol and control sleep in the
mean oxygen saturation, Change in mean ΔPtcCO2 difference between
alcohol and control sleep in the mean increase from awake, supine,
transcutaneous carbon dioxide pressure, BMI body mass index, PaO2
arterial pressure of oxygen, PaCO2 arterial pressure of carbon dioxide,
FVC% of pred forced vital capacity as percent of predicted value, FEV1%
of pred forced expiratory volume first second as percent of predicted
value, DLCO diffusing capacity of the lung for carbon monoxide, RV
residual volume, TLC total lung capacity, Change in REM % of TST
difference in the mean rapid eye movement sleep percent of total sleep
time between alcohol and control sleep, Change in awakenings difference
in the number of awakenings between alcohol and control sleep
a Partial correlation controlling for LTOT use is tabulated
b Four missing from DLCO because of insufficient vital capacity or
because they could not hold their breath for 10 s
c Two missing from body plethysmography because of claustrophobia
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subjects; however, it has some limitations. Many comparisons
increase the risk of type 1 statistical errors (falsely rejecting
the null hypothesis when in fact it is true) and although an
alpha-correction was applied in interpreting the results of
analyses other than the main hypothesis, the significance of
the results must be viewed with this risk in mind. The open-
label design can add a placebo bias to the alcohol intervention.
However, we find it less likely that ventilation during sleep is
affected by the knowledge of being drunk, and the fact that
blood gases were unchanged when awake after initial sleep
onset indicates little placebo impact. Another limitation is the
lack of a detailed, structured alcohol consumption interview,
as regular alcohol ingestion, although not being considered as
a drinking problem, can result in a very different sleep and
breathing patterns as discussed above. Thirdly, no records
were made of whether or not the study subjects were fasting
at the time of alcohol ingestion. The alcohol breath test per-
formed immediately before lights off was not considered a
valid measurement of blood alcohol content (BAC) as such
analyses are considered to be unreliable in COPD [28–30];
nevertheless, the breath analyses showed an unexpected high
variability (Table 1). Food taken together with alcohol can
delay peak BAC, possibly explaining some of this variability.
If BAC correlates withΔPtcCO2, fasting individuals can have
peak BACs and thus highΔPtcCO2, values early in the night,
compared to those with their BAC peak well into the night.
However, supper at the hospital was at 6:30 p.m., and we find
it unlikely that many study subjects ate at a later time.
Conclusion/summary
In this study of stable COPD patients drinking a moderate
dose of alcohol immediately prior to lights off, we found a
very modest sleep hypoventilation as increased mean
ΔPtcCO2, a reduced REM % of TST, and no changes in
AHI. However, this combination of hypoventilation and
decreased REM-sleep time was evident in less than half
of the subjects, as about one-fourth had a minor sleep
hyperventilation with reduced REM % of TST and another
one-fourth was hypoventilating with an increase in REM%of
TST. Also, subjects with COPD and OSA (overlap) had lower
median AHI and ODI in alcohol-sleep versus control sleep.
We found an association between daytime blood gases and
alcohol-sleep hypoventilation as decreased SpO2, but not in-
creased ΔPtcCO2, and a regression model with the variables
LTOT-use, PaO2, and PaCO2 could explain 49 % of the vari-
ation in alcohol sleep SpO2 change. As the blood gas changes
were minor, the clinical implication of this study is that a
single, moderate, bedtime dose of alcohol seems to have only
minor respiratory depressant effects on the majority of COPD
subjects, and in a minority even slightly improves respiration
during sleep. However, caution must be applied as the study is
small, and higher doses of alcohol may result in major respi-
ratory depressive and additional negative health effects.
Acknowledgments Financial support was received from the Norwe-
gian ExtraFoundation for Health and Rehabilitation, LHL’s Research
fund, Glittreklinikken LHL helse as and the Norwegian national centre
of excellence in homemechanical ventilation. Minor grants received from
the Norwegian lung medicine society/Takeda Nycomed, Major Eckbo’s
endowments and the University of Bergen. PSG hardware and software
were provided by ResMed Norway.
Conflict of interests This is not an industry supported study.
Nils Henrik Holmedahl: Has received lecture honorarium from Glaxo
Smith Kline and a grant from the Norwegian Lung Medicine Society/
Takeda Nycomed.
Britt Øverland: No conflict of interest.
Ove Fondenes: No conflict of interest.
Ivar Ellingsen: No conflict of interest.
Jon Andrew Hardie: No conflict of interest.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS,
Schmid V, Buist S (2006/2) Chronic obstructive pulmonary disease:
current burden and future projections. Eur Respir J 27(2):397–412
2. McNicholas WT, Fitzgerald MX (1984) Nocturnal deaths among
patients with chronic bronchitis and emphysema. Br Med J (Clin
Res Ed) 289(6449):878
3. Costello R, Deegan P, Fitzpatrick M, McNicholas WT (1997/3)
Reversible hypercapnia in chronic obstructive pulmonary disease: a
distinct pattern of respiratory failure with a favorable prognosis. Am J
Med 102(3):239–244
4. Lebowitz MD (1981) Respiratory symptoms and disease related to
alcohol consumption. Am Rev Respir Dis 123(1):16–19
5. Lange P, Groth S, Mortensen J, Appleyard M, Nyboe J, Jensen G,
Schnohr P (1988) Pulmonary function is influenced by heavy alcohol
consumption. Am Rev Respir Dis 137(5):1119–1123. doi:10.1164/
ajrccm/137.5.1119
6. Sisson JH, Stoner JA, Romberger DJ, Spurzem JR, Wyatt TA,
Owens-Ream J, Mannino DM (2005) Alcohol intake is associated
with altered pulmonary function. Alcohol 36(1):19–30. doi:10.1016/
j.alcohol.2005.05.002
7. Tabak C, Smit HA, Rasanen L, Fidanza F, Menotti A, Nissinen A,
Feskens EJ, Heederik D, Kromhout D (2001) Alcohol consumption
in relation to 20-year COPD mortality and pulmonary function in
middle-aged men from three European countries. Epidemiology
12(2):239–245
8. Tabak C, Smit HA, Heederik D, Ocke MC, Kromhout D (2001) Diet
and chronic obstructive pulmonary disease: independent beneficial
effects of fruits, whole grains, and alcohol (the MORGEN study).
Clin Exp Allergy 31(5):747–755
9. Sahn SA, Lakshminarayan S, Pierson DJ, Weil JV (1975) Effect of
ethanol on the ventilatory responses to oxygen and carbon dioxide in
man. Clin Sci Mol Med 49(1):33–38
10. O’Donoghue FJ, Catcheside PG, Ellis EE, Grunstein RR, Pierce RJ,
Rowland LS, Collins ER, Rochford SE,McEvoy RD, Australian trial
of Noninvasive Ventilation in Chronic Airflow Limitation i (2003)
Sleep Breath
Sleep hypoventilation in hypercapnic chronic obstructive pulmonary
disease: prevalence and associated factors. Eur Respir J 21(6):
977–984
11. Tarrega J, Anton A, Guell R, Mayos M, Samolski D, Marti S, Farrero
E, Prats E, Sanchis J (2011) Predicting nocturnal hypoventilation in
hypercapnic chronic obstructive pulmonary disease patients
undergoing long-term oxygen therapy. Respiration 82(1):4–9.
doi:10.1159/000321372
12. Holmedahl NH, Øverland B, Fondenes O, Ellingsen I, Hardie
JA (2014) Sleep hypoventilation and daytime hypercapnia in
stable chronic obstructive pulmonary disease. Int J COPD 9:
265–275
13. Taasan VC, Block AJ, Boysen PG, Wynne JW (1981/8) Alcohol
increases sleep apnea and oxygen desaturation in asymptomatic men.
Am J Med 71(2):240–245
14. Dolly FR, Block AJ (1983) Increased ventricular ectopy and sleep
apnea following ethanol ingestion in COPD patients. Chest 83(3):
469–472
15. Block AJ, Hellard DW, Slayton PC (1985) Minimal effect of alcohol
ingestion on breathing during the sleep of postmenopausal women.
Chest 88(2):181–184
16. Yules RB, Lippman ME, Freedman DX (1967) Alcohol administra-
tion prior to sleep. The effect on EEG sleep stages. Arch Gen
Psychiatry 16(1):94–97
17. Easton PA,West P, Meatherall RC, Brewster JF, LertzmanM, Kryger
MH (1987) The effect of excessive ethanol ingestion on sleep in
severe chronic obstructive pulmonary disease. Sleep 10(3):224–233
18. Global Initiative for Chronic Obstructive Pulmonary Disease
(GOLD). Global strategy for the diagnosis, treatment, and prevention
of chronic obstructive pulmonary disease. Updated 2013. Available
from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_
2013_Feb20.pdf. Accessed 25 Feb 2014
19. American Academy of SleepMedicine (2007) The AASMmanual for
the scoring of sleep and associated events. In: Iber C, Ancoli-Israel S,
Chesson AL, Quan SF (eds) Rules, terminology and technical speci-
fications. American Academy of Sleep Medicine, Westchester
20. Paton A, Saunders JB (1981) ABC of alcohol. Definitions. Br Med J
(Clin Res Ed) 283(6301):1248–1250
21. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R,
Yernault JC (1993) Lung volumes and forced ventilatory flows.
Report Working Party Standardization of Lung Function Tests,
European Community for Steel and Coal. Official Statement of the
European Respiratory Society. Eur Respir J Suppl 16:5–40
22. Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK,
Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl
KP, Davidson Ward SL, Tangredi MM, American Academy of Sleep
M (2012) Rules for scoring respiratory events in sleep: update of the
2007 AASMManual for the Scoring of Sleep and Associated Events.
Deliberations of the Sleep Apnea Definitions Task Force of the
American Academy of Sleep Medicine. J Clin Sleep Med JCSM
Off Publ AmAcad Sleep Med 8(5):597–619. doi:10.5664/jcsm.2172
23. Brander PE, Kuitunen T, Salmi T, Partinen M (1992) Nocturnal
oxygen saturation in advanced chronic obstructive pulmonary dis-
ease after a moderate dose of ethanol. Eur Respir J 5(3):308–312
24. Sisson JH (2007) Alcohol and airways function in health and disease.
Alcohol 41(5):293–307. doi:10.1016/j.alcohol.2007.06.003
25. Mitler MM, Dawson A, Henriksen SJ, Sobers M, Bloom FE
(1988/12) Bedtime ethanol increases resistance of upper airways
and produces sleep apneas in asymptomatic snorers. Alcohol Clin
Exp Res 12(6):801–805
26. Scanlan MF, Roebuck T, Little PJ, Redman JR, Naughton MT
(2000/11) Effect of moderate alcohol upon obstructive sleep apnoea.
Eur Respir J 16(5):909–913
27. Sahn SA, Scoggin CH, Chernow B (1979) Moderate alcohol dose
and chronic obstructive pulmonary disease: not a cause of
hypoventilation. Arch Intern Med 139(4):429–431
28. Russell JC, Jones RL (1983) Breath ethyl alcohol concentration and
analysis in the presence of chronic obstructive pulmonary disease.
Clin Biochem 16(3):182–187
29. Wilson A, Sitar DS, Molloy WD, McCarthy D (1987) Effect of age
and chronic obstructive pulmonary disease on the Breathalyzer esti-
mation of blood alcohol level. Alcohol Clin Exp Res 11(5):440–443
30. Honeybourne D,Moore AJ, Butterfield AK, Azzan L (2000) A study
to investigate the ability of subjects with chronic lung diseases to
provide evidential breath samples using the Lion Intoxilyzer 6000
UK breath alcohol testing device. Respir Med 94(7):684–688
Sleep Breath
